Desq Long
Sign in

Company

Adaptive Biotechnologies Corp

ADPT · CIK 0001478320

SEC FORM 4
$644,524.74

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 53,091 shares at $12.14 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$113,347.08

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 13,398 shares at $8.46 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$62,359.71

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 15,629 shares at $3.99 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$190,349.04

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 23,442 shares at $8.12 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$3,013,186.74

Adaptive Biotechnologies Corp (ADPT)

Sale of 107,537 shares at $28.02 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$224,817.33

Adaptive Biotechnologies Corp (ADPT)

Sale of 7,869 shares at $28.57 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$32,265.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 1,195 shares at $27.00 per share.

Reporting Person BOBULSKY SUSAN · Officer Title Chief Commercial Officer, MRD · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001820885-26-000023 · filed 2026-09-17 · View filing →

SEC FORM 4
$249,990.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 9,615 shares at $26.00 per share.

Reporting Person OWEN KATEY EINTERZ · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001852578-26-000005 · filed 2026-08-28 · View filing →

SEC FORM 4
$94,800.00

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 15,000 shares at $6.32 per share.

Reporting Person HERSHBERG ROBERT · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001274139-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
$365,850.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 15,000 shares at $24.39 per share.

Reporting Person HERSHBERG ROBERT · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001274139-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
$382,358.24

Adaptive Biotechnologies Corp (ADPT)

Sale of 15,664 shares at $24.41 per share.

Reporting Person HERSHBERG ROBERT · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001274139-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
$1,825,327.80

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 278,676 shares at $6.55 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$6,816,994.56

Adaptive Biotechnologies Corp (ADPT)

Sale of 278,472 shares at $24.48 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$5,128.56

Adaptive Biotechnologies Corp (ADPT)

Sale of 204 shares at $25.14 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$94,800.00

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 15,000 shares at $6.32 per share.

Reporting Person NEUPERT PETER M · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001237566-26-000003 · filed 2026-08-19 · View filing →

SEC FORM 4
$378,450.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 15,000 shares at $25.23 per share.

Reporting Person NEUPERT PETER M · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001237566-26-000003 · filed 2026-08-19 · View filing →

SEC FORM 4
$1,004,000.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 40,000 shares at $25.1 per share.

Reporting Person NEUPERT PETER M · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001237566-26-000003 · filed 2026-08-19 · View filing →

SEC FORM 4
$1,753,400.40

Adaptive Biotechnologies Corp (ADPT)

Sale of 69,690 shares at $25.16 per share.

Reporting Person NEUPERT PETER M · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001237566-26-000003 · filed 2026-08-19 · View filing →

SEC FORM 4
$2,104,672.20

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 321,324 shares at $6.55 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$7,995,478.92

Adaptive Biotechnologies Corp (ADPT)

Sale of 318,799 shares at $25.08 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$64,564.25

Adaptive Biotechnologies Corp (ADPT)

Sale of 2,525 shares at $25.57 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$75,000.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 3,000 shares at $25.00 per share.

Reporting Person BOBULSKY SUSAN · Officer Title Chief Commercial Officer, MRD · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001820885-26-000020 · filed 2026-08-12 · View filing →